- Health and nutrition business Benchmark said Thursday adjusted profits rose 19%, led by a jump in revenue from its genetics division.

For the 12 months ended 31 December, adjusted profit, which excluded exceptional cost, rose 19% to £5.6m and revenue increased by 8% to £151.5m.

Revenue growth was led by genetics up 21%; Advanced Nutrition up 9%; and Animal Health up 7%, the company said.

When exceptional costs related to initiation of new production facilities, increased finance and credit costs are included, pre-tax losses widened to £13.7m from £8.1m a year earlier.

Exceptional costs included a rise in depreciation, amortisation and impairment charges to £24.8m for the year, from £23.4m a year earlier, principally relating to the new production facilities coming on stream. While the increase in finance costs and a credit in exceptional costs in the prior year of £5.6m also weighed down performance.

Adjusted earnings (EBITDA) rose 68% to £17.0m, led by a 36% increase in Genetics, a 22% increase in Advanced Nutrition, the company said.

At 10:08am: [LON:BMK] Benchmark Holdings Plc share price was 0p at 58.5p

Story provided by